Trial Profile
Mechanistic Trial of Dupilumab in Adults With House Dust Mite-associated Asthma Using an Aeroallergen Challenge Chamber
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 09 Apr 2024
Price :
$35
*
At a glance
- Drugs Dupilumab (Primary)
- Indications Allergic asthma
- Focus Pharmacodynamics
- 06 Apr 2023 Planned initiation date (estimated date for recruitment of the first subject) changed from 1 Mar 2023 to 1 May 2023.
- 06 Apr 2023 Status changed from not yet recruiting to recruiting.
- 14 Feb 2023 New trial record